Well-being in IBS: Strengths and Happiness (WISH) 2.0
The WISH Intervention for IBS: Feasibility, Preliminary Effects, and Candidate Gut-Brain Mechanisms
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to examine the feasibility, acceptability, preliminary effects, and candidate gut-brain mechanisms of an optimized positive psychology (PP) intervention for patients with irritable bowel syndrome (IBS), entitled "WISH," compared to an educational control intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2025
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedStudy Start
First participant enrolled
October 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2028
April 22, 2026
April 1, 2026
2.4 years
March 4, 2025
April 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Proportion of Intervention Sessions Completed by Participants
Feasibility will be measured by the proportion of intervention sessions completed by participants. The intervention will be considered feasible if at least 50% of participants complete at least 6/9 sessions.
Post-intervention at 9 weeks
Ease of Weekly Exercises
Participants will provide ratings of ease after each weekly exercise, measured on a 10-point Likert scale (0=very difficult, 10=very easy).
Weekly during intervention (weeks 1-8) and post-intervention (week 9)
Utility of Weekly Exercises
Participants will provide ratings of utility after each weekly exercise, measured on a 10-point Likert scale (0=not at all helpful; 10=very helpful).
Weekly during intervention (weeks 1-8) and post-intervention (week 9)
Secondary Outcomes (24)
Immediate Impact of the Exercises: Change in Optimism Ratings
Weeks 1-9
Immediate Impact of the Exercises: Change in Happiness Ratings
Weeks 1-9
Immediate Impact of the Exercises: Change in IBS Knowledge Ratings
Weeks 1-9
Change in IBS Symptom Severity
At baseline (week 1), at the mid-point of the intervention (week 5), post-intervention (week 9), and 3-months post-intervention (week 21)
Change in IBS Health-Related Quality of Life
At baseline (week 1), at the mid-point of the intervention (week 5), post-intervention (week 9), and 3-months post-intervention (week 21)
- +19 more secondary outcomes
Study Arms (2)
Positive Psychology (PP) Intervention
EXPERIMENTALParticipants will complete an adapted, optimized, phone-based, 9-week positive psychology (PP) intervention.
Educational Intervention
ACTIVE COMPARATORParticipants will complete a 9-week, phone-based educational intervention that matches the PP intervention in terms of both time and attention.
Interventions
This is an adapted, optimized, phone-based, 9-week positive psychology (PP) intervention. Participants will complete 9 weekly phone sessions (30 minutes each) with a study interventionist in which they will review PP exercises that they have independently completed in between phone sessions. The PP exercises will be completed in a treatment manual that describes the PP exercise and provides space to write about the exercise and its effects, and to answer associated questions. A total of 9 sessions will be completed over the course of the program.
This is an educational intervention that will match the PP intervention in terms of both time and attention. Participants will complete 9 weekly phone sessions (30 minutes each) with a study interventionist in which they will review educational exercises that they have independently completed in between phone sessions. The exercises will be completed in a treatment manual that describes the exercise and provides space to write about the exercise and its effects, and to answer associated questions. A total of 9 sessions will be completed over the course of the program.
Eligibility Criteria
You may qualify if:
- IBS Diagnosis: Adult patients with an IBS diagnosis meeting standardized Rome IV diagnostic criteria.
- Language and communication: English fluency and access to a phone.
You may not qualify if:
- Presence of inflammatory bowel disease or other structural/biochemical primary gastrointestinal illness that better explains IBS-like symptoms: As reported by the patient, their physician, and/or documented in the medical record.
- Severe psychiatric illness: Current manic episode, psychosis, or active substance use disorder diagnosed via the Mini International Neuropsychiatric Interview (MINI).
- Cognitive impairment: Assessed using a six-item cognitive screen developed for research.
- Presence of atrial fibrillation or a cardiac pacemaker, or daily use of beta blocking medication: As reported by the patient and/or documented in the medical record.
- Plans to start or participate in another new behavioral health intervention or psychotherapy during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth N Madva, MD
Massachusetts General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychiatry
Study Record Dates
First Submitted
March 4, 2025
First Posted
March 10, 2025
Study Start
October 30, 2025
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
April 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Datasets will be provided to respective repositories by the end of the funding period. The clinical data shared with the Vivli repository will be archived and available for request by researchers for a minimum of 10 years after contribution. Genomic data will be preserved in the dbGaP/SRA repositories for at least three years following the completion of the grant.
- Access Criteria
- Clinical and genomic data will be shared with controlled access with the Vivli repository and dbGaP/SRA, respectively, for general research use, as allowed by the participants' informed consents and the Institutional Certification. Access to data requires the completion of a Data Use Agreement (DUA), which prohibits any redistribution or attempts to re-identify research participants.
To help advance other research, de-identified data will be shared via respective repositories as specified below: * Clinical data including demographics, self-report questionnaires, and heart-rate variability will be shared via the Vivli repository. * Genomic data generated from RNA-seq will be submitted as FASTQ files to the Database of Genotypes and Phenotypes (dbGaP) which will then be shared to the Sequence Read Archive (SRA) with controlled access.